Daniel H. Gonzalez Maglio
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Daniel H. Gonzalez Maglio has a total of 137 co-authors. Here are the top co-authors by number of shared publications:
Juliana Leoni
CONICET, Universidad de Buenos Aires, Instituto de Estudios de la Inmunidad Humoral (IDEHU)
17 shared publicationsMariela L. Paz
Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Cátedra de Inmunología Buenos Aires Argentina
10 shared publications- Eliana M. Cela
Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires C1425FQB, Argentina
9 shared publications - Mariela Laura Paz
Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Cátedra de Inmunología, Buenos Aires, Argentina
8 shared publications Alejandro Ferrari
Cátedra de Inmunología, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Junín 956, 4to Piso, Ciudad Autónoma de Buenos Aires, C.P. 1113, Argentina
7 shared publicationsFederico S. Weill
Facultad de Farmacia y Bioquímica Universidad de Buenos Aires Buenos Aires Argentina
6 shared publications
Latest Publications
- 16 May 2025
- Published by Wiley in Photochemistry and Photobiology
Beyond ultraviolet radiation: Immune system modulation through skin exposure to visible light and infrared radiation
Sunlight profoundly affects skin health when it is exposed. After acute exposure, a robust inflammatory response is initiated locally. Moreover, chronic exposures lead to carcinogenesis and photoaging. Local and systemic immunosuppression is also triggered after skin irradiation, affecting adaptive immune responses. These effects are mainly produced by the ultraviolet radiation contained in sunlight and were extensively described and reviewed. However, using UV filters during sunbathing and outdoor activities may allow visible light (VL) wavelengths and infrared radiation (IRR) to reach skin cells. Additionally, the employment of therapeutic VL and IR‐emitting lasers and LED devices is increasing for various skin conditions. This literature review aims to present current knowledge on the effects of VL and IRR modulating the skin and systemic immune system. These modulations impact healthy skin and can modify immune responses to diverse stimuli in various cell types. According to the wavelength and the dose, VL and IRR increase the production of reactive oxygen species and promote faster wound healing. Moreover, they modulate inflammatory mediators, such as several cytokines and prostaglandins. However, skin exposure to VL can also affect adaptive immune responses. The study of VL and IRR effects on immunity would promote new uses for phototherapy and may establish the need for new strategies in photoprotection.
- 16 May 2025
- Published by Wiley in Photochemistry and Photobiology
Beyond ultraviolet radiation: Immune system modulation through skin exposure to visible light and infrared radiation
Sunlight profoundly affects skin health when it is exposed. After acute exposure, a robust inflammatory response is initiated locally. Moreover, chronic exposures lead to carcinogenesis and photoaging. Local and systemic immunosuppression is also triggered after skin irradiation, affecting adaptive immune responses. These effects are mainly produced by the ultraviolet radiation contained in sunlight and were extensively described and reviewed. However, using UV filters during sunbathing and outdoor activities may allow visible light (VL) wavelengths and infrared radiation (IRR) to reach skin cells. Additionally, the employment of therapeutic VL and IR‐emitting lasers and LED devices is increasing for various skin conditions. This literature review aims to present current knowledge on the effects of VL and IRR modulating the skin and systemic immune system. These modulations impact healthy skin and can modify immune responses to diverse stimuli in various cell types. According to the wavelength and the dose, VL and IRR increase the production of reactive oxygen species and promote faster wound healing. Moreover, they modulate inflammatory mediators, such as several cytokines and prostaglandins. However, skin exposure to VL can also affect adaptive immune responses. The study of VL and IRR effects on immunity would promote new uses for phototherapy and may establish the need for new strategies in photoprotection.
- Open Access
- 8 September 2023
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 13 (39) , 27391-27402
Amidinoquinoxaline N -oxides: synthesis and activity against anaerobic bacteria
Amidinoquinoxaline N -oxides 1 show high antianaerobic activity, with CIM significantly lower than metronidazole in six cases, along with low cytotoxicity and promising ADME profiles. These nitrones represent a promising alternative to metronidazole.
- 8 September 2023
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 13 (39) , 27391-27402
Open AccessAmidinoquinoxaline N -oxides: synthesis and activity against anaerobic bacteria
Amidinoquinoxaline N -oxides 1 show high antianaerobic activity, with CIM significantly lower than metronidazole in six cases, along with low cytotoxicity and promising ADME profiles. These nitrones represent a promising alternative to metronidazole.
- 19 August 2023
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 107 (4) , 116060
Evaluation of the Histoplasma capsulatum 100-kilodalton antigen dot blot for the rapid diagnosis of progressive histoplasmosis in HIV/AIDS patients
- 19 August 2023
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 107 (4) , 116060
Evaluation of the Histoplasma capsulatum 100-kilodalton antigen dot blot for the rapid diagnosis of progressive histoplasmosis in HIV/AIDS patients
Role of recombinant Histoplasma capsulatum 100‐kilodalton antigen in the diagnosis of histoplasmosis among HIV/AIDS patients: Antigenuria and antibodies detection
Background: Diagnosing progressive disseminated histoplasmosis (PDH) is still challenging in many countries where this disease is highly endemic. Definitive diagnosis is established by culture and/or by cytology/histopathology but both procedures have limited sensitivity and cultures are time‐consuming. Antibodies detection by immunodiffusion has a low sensitivity in immunocompromised individuals. Commercially available antigen detection assays have high sensitivity in PDH cases; however, they are expensive and only performed in few laboratories.Aims: To describe the potential use of a novel ELISA for antibodies testing and a dot blot assay for antigen testing for diagnosing PDH using the recombinant 100 kDa protein of Histoplasma capsulatum (Hcp100) and their polyclonal antibodies as novel reagents, respectively.Methods: Serum and urine samples from a cohort of patients with HIV/AIDS and proven PDH were studied for the detection of anti‐Hcp100 antibodies by ELISA and Hcp100 antigen by dot blot, respectively. Sensitivity, specificity and cross‐reactions with other diseases were estimated for each assay and compared with those obtained using histoplasmin (HMN) as a reagent for antibodies detection by ELISA and immunodiffusion, and using a commercial antigenuria test.Results: Antibodies detection by the Hcp100 ELISA demonstrated 78.6% sensitivity and 88.4% specificity, versus 85.7% sensitivity and 81.0% specificity for the HMN ELISA and 26.1% sensitivity and 100% specificity for the immunodiffusion assay. Antigen detection by the Hcp100 dot blot demonstrated 89.3% sensitivity and 97.0% specificity versus 82.1% sensitivity and 90.9% specificity for the commercial test.Conclusion: The immunoassays described herein based on Hcp100 would be a valuable screening tool for diagnosing PDH.
Role of recombinant Histoplasma capsulatum 100‐kilodalton antigen in the diagnosis of histoplasmosis among HIV/AIDS patients: Antigenuria and antibodies detection
Background: Diagnosing progressive disseminated histoplasmosis (PDH) is still challenging in many countries where this disease is highly endemic. Definitive diagnosis is established by culture and/or by cytology/histopathology but both procedures have limited sensitivity and cultures are time‐consuming. Antibodies detection by immunodiffusion has a low sensitivity in immunocompromised individuals. Commercially available antigen detection assays have high sensitivity in PDH cases; however, they are expensive and only performed in few laboratories.Aims: To describe the potential use of a novel ELISA for antibodies testing and a dot blot assay for antigen testing for diagnosing PDH using the recombinant 100 kDa protein of Histoplasma capsulatum (Hcp100) and their polyclonal antibodies as novel reagents, respectively.Methods: Serum and urine samples from a cohort of patients with HIV/AIDS and proven PDH were studied for the detection of anti‐Hcp100 antibodies by ELISA and Hcp100 antigen by dot blot, respectively. Sensitivity, specificity and cross‐reactions with other diseases were estimated for each assay and compared with those obtained using histoplasmin (HMN) as a reagent for antibodies detection by ELISA and immunodiffusion, and using a commercial antigenuria test.Results: Antibodies detection by the Hcp100 ELISA demonstrated 78.6% sensitivity and 88.4% specificity, versus 85.7% sensitivity and 81.0% specificity for the HMN ELISA and 26.1% sensitivity and 100% specificity for the immunodiffusion assay. Antigen detection by the Hcp100 dot blot demonstrated 89.3% sensitivity and 97.0% specificity versus 82.1% sensitivity and 90.9% specificity for the commercial test.Conclusion: The immunoassays described herein based on Hcp100 would be a valuable screening tool for diagnosing PDH.
- Open Access
Lipoteichoic Acid from Lacticaseibacillus rhamnosus GG Modulates Dendritic Cells and T Cells in the Gut
Lipoteichoic acid (LTA) from Gram-positive bacteria exerts different immune effects depending on the bacterial source from which it is isolated. Lacticaseibacillus rhamnosus GG LTA (LGG-LTA) oral administration reduces UVB-induced immunosuppression and skin tumor development in mice. In the present work, we evaluate the immunomodulatory effect exerted by LGG-LTA in dendritic cells (DC) and T cells, both in vitro and in the gut-associated lymphoid tissue (GALT). During cell culture, LTA-stimulated BMDC increased CD86 and MHC-II expression and secreted low levels of pro and anti-inflammatory cytokines. Moreover, LTA-treated BMDC increased T cell priming capacity, promoting the secretion of IL-17A. On the other hand, in orally LTA-treated mice, a decrease in mature DC (lamina propria and Peyer’s patches) was observed. Concomitantly, an increase in IL-12p35 and IFN-γ transcription was presented (lamina propria and Peyer’s Patches). Finally, an increase in the number of CD103+ DC was observed in Peyer’s patches. Together, our data demonstrate that LGG-LTA activates DC and T cells. Moreover, we show that a Th1-biased immune response is triggered in vivo after oral LTA administration. These effects justify the oral LTA activity previously observed.
Open AccessLipoteichoic Acid from Lacticaseibacillus rhamnosus GG Modulates Dendritic Cells and T Cells in the Gut
Lipoteichoic acid (LTA) from Gram-positive bacteria exerts different immune effects depending on the bacterial source from which it is isolated. Lacticaseibacillus rhamnosus GG LTA (LGG-LTA) oral administration reduces UVB-induced immunosuppression and skin tumor development in mice. In the present work, we evaluate the immunomodulatory effect exerted by LGG-LTA in dendritic cells (DC) and T cells, both in vitro and in the gut-associated lymphoid tissue (GALT). During cell culture, LTA-stimulated BMDC increased CD86 and MHC-II expression and secreted low levels of pro and anti-inflammatory cytokines. Moreover, LTA-treated BMDC increased T cell priming capacity, promoting the secretion of IL-17A. On the other hand, in orally LTA-treated mice, a decrease in mature DC (lamina propria and Peyer’s patches) was observed. Concomitantly, an increase in IL-12p35 and IFN-γ transcription was presented (lamina propria and Peyer’s Patches). Finally, an increase in the number of CD103+ DC was observed in Peyer’s patches. Together, our data demonstrate that LGG-LTA activates DC and T cells. Moreover, we show that a Th1-biased immune response is triggered in vivo after oral LTA administration. These effects justify the oral LTA activity previously observed.
- 1 February 2022
- Published by Elsevier in Environmental Pollution
- Vol. 295, 118677
Chronic exposure to polluted urban air aggravates myocardial infarction by impaired cardiac mitochondrial function and dynamics
- 1 February 2022
- Published by Elsevier in Environmental Pollution
- Vol. 295, 118677
Chronic exposure to polluted urban air aggravates myocardial infarction by impaired cardiac mitochondrial function and dynamics
- Open Access
- 23 November 2021
- Published by Springer Nature
- p. 147-172
Probiotic Effects on Skin Health: The Case of Photoprotection as a Model of Gut-Skin Dialog
- 23 November 2021
- Published by Springer Nature
- p. 147-172
Open AccessProbiotic Effects on Skin Health: The Case of Photoprotection as a Model of Gut-Skin Dialog
- 1 January 2021
- Published by Elsevier
- p. 285-308
Bioenergetic profiling in the skin
- Open Access
- 1 December 2020
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 205, 111186
NADPH oxidase and mitochondria are relevant sources of superoxide anion in the oxinflammatory response of macrophages exposed to airborne particulate matter
- 1 December 2020
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 205, 111186
Open AccessNADPH oxidase and mitochondria are relevant sources of superoxide anion in the oxinflammatory response of macrophages exposed to airborne particulate matter